1.50575

LiChrospher^® RP-select B (5 µm) HPLC Columns

L x I.D. 250 mm x 4.6 mm Hibar^® RT HPLC Column

• 别名: TM=["LiChrospher"] C8 HPLC column
• 分類程式碼代碼: 41115709
• NACRES: SB.52

属性

• product name: LiChrospher^® RP-select B (5µm) Hibar^® RT 250-4.6, suitable for HPLC
• 材料: stainless steel column
• 品質等級: 100
• agency: suitable for USP L7
• 產品線: LiChrospher^®
• 特點: endcapped: no
• 標籤範圍: 11.5% Carbon loading
• 參數: 400 bar pressure; 60 °C max. temp.
• 技術: HPLC: suitable; mass spectrometry (MS): suitable (Low - Medium)
• 柱長度 × 內徑: 25 cm × 4.6 mm
• 表面積: 350 m²/g
• 基質: fully porous particle
• 基質活性組: C8 bonding phase
• 粒徑: 5 μm
• 孔徑: 60 Å pore size
• 工作pH值範圍: 2-7.5
• 分離技術: reversed phase; supercritical fluid (SFC)
• 儲存溫度: no temp limit

说明

一般說明

HPLC色谱柱

LiChrospher^® RP-select B 是一个通用的用传统方法生产的球形硅胶载体，具有反相特性和C-8相的疏水性。这个载体非常适合于碱性化合物的分离，但在中性和酸性化合物的测定中也有较好的性能。该吸附剂装在 Hibar 100-4.6 HPLC 柱中。在安装LiChroCART 4-4保护柱时，必须使用保护柱支架1.51487。

應用

• Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD: This study utilizes high-performance liquid chromatography with diode-array detection (HPLC-DAD), employing a LiChrospher^® RP-select B column to effectively separate and quantify cannabinoids in forensic samples, highlighting its application in legal and forensic settings (Ambach et al., 2014).


• Structural characterization of stress degradation products of Darunavir: Employing LC-MS/MS alongside HPLC, this research underscores the utility of the LiChrospher^® RP-select B column in the stability analysis of HIV medications, crucial for ensuring drug safety and efficacy (Rao et al., 2014).


• RP-HPLC separation and characterization of unknown impurities of Darunavir: This study demonstrates the column′s role in identifying and quantifying impurities in HIV-protease inhibitors, contributing to the pharmaceutical industry′s quality control measures (Nageswara Rao et al., 2013).


• Quantification of pralidoxime in urine by ion pair chromatography: The LiChrospher^® RP-select B column is applied in a biomedical context to monitor therapeutic agents in clinical settings, supporting patient treatment regimes (John et al., 2012).


• Liquid chromatography/electrospray tandem mass spectrometry method for determination of cefuroxime: This analytical method facilitates the study of pharmacokinetics in clinical pharmacology, using the LiChrospher^® RP-select B column for precise drug monitoring in plasma (Partani et al., 2010).

分析報告

压力： ≤ 90 bar
理论塔板数（N/m）（甲苯）： ≥ 50000
对称性（甲苯）：0.8-1.4
容量系数（甲苯）：1.0 - 2.0

法律資訊

Hibar is a registered trademark of Merck KGaA, Darmstadt, Germany

LiChrospher is a registered trademark of Merck KGaA, Darmstadt, Germany